GlassScriptPhysician profile
Max Bowman
NPI 1801391990
$9,205.89
in general payments reported to CMS, 2019-2025
10 companies · $828 in 2025
The $828 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $79.28 · 2021: $49.94 · 2022: $5,569 · 2023: $427 · 2024: $2,252 · 2025: $828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,649 · Food and Beverage: $1,633 · Consulting Fee: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,649.39 |
| Food and Beverage | $1,632.90 |
| Consulting Fee | $225.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calyxo, INC. | $5,274.95 | 2022-2023 | Cvac Aspiration System |
| Boston Scientific Corporation | $2,209.66 | 2021-2025 | Moses, Lithovue, Ams 700 |
| Intuitive Surgical, INC. | $1,163.00 | 2024 | |
| Urogen Pharma, INC. | $154.61 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $122.32 | 2025 | Bard Urinary Drainage Bag |
| Cook Medical LLC | $114.27 | 2025 | Litho 150 |
| Neotract INC. | $79.28 | 2020 | |
| Olympus America INC. | $35.99 | 2025 | Itind System |
| Procept Biorobotics Corporation | $31.92 | 2024 | Aquabeam System |
| Ethicon US, LLC | $19.89 | 2024 | Harmonic, Echelon Flex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Max Bowman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.